

Please try another search
For the three months ended 31 March 2022, Bruker Corporation revenues increased 7% to $595M. Net income increased 9% to $61.6M. Revenues reflect BSI NANO segment increase of 16% to $178.5M, BSI Life Science segment increase of 3% to $361M, Bruker Energy & Supercon Technologies segment increase of 14% to $59.7M, United States segment increase of 30% to $155M, Other segment increase of 39% to $49.2M.
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Revenue | 595 | 683.5 | 608.9 | 570.8 |
Gross Profit | 306.3 | 341.6 | 308.7 | 280.6 |
Operating Income | 96.5 | 125.4 | 113.2 | 85.6 |
Net Income | 61.6 | 75.7 | 87.1 | 57.6 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Assets | 3550.7 | 3650 | 3127.7 | 3087 |
Total Liabilities | 2533.7 | 2579.5 | 2052.1 | 2085 |
Total Equity | 1017 | 1070.5 | 1075.6 | 1002 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Period Length: | 0 Months | 12 Months | 9 Months | 0 Months |
Cash From Operating Activities | 77.8 | 282.4 | 143.8 | 119.9 |
Cash From Investing Activities | -101.8 | -192.4 | -143.8 | -95.4 |
Cash From Financing Activities | -217.4 | 318.7 | -85.6 | -83 |
Net Change in Cash | -252.1 | 386.2 | -109 | -73.8 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review